Sex hormone receptors in varicose veins of women with premenstrual syndrome

Phlebologie

Volumn 37, Issue 2, 2008, Pages 68-72

  Krasinski, Zbigniew ^a,b   Dzieciuchowicz, L ^a   Kotwicka, M ^a   Gabriel, M ^a   Szczesniak Chmielecka A ^a   Krasinska B ^a   Oszkinis, G ^a   Majewski, W ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Clinical Hospital Nr 1   (Poland)

Author keywords

Premenstrual tension syndrome; Sex hormones; Varicose veins

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; PREMENSTRUAL SYNDROME; PREVALENCE; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; VARICOSIS;

EID: 44649097557     PISSN: 0939978X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1622215     Document Type: Article

References (25)

1. Bergqvist A, Bergqvist D, Ferno M. Estrogen and progesterone receptors in vessel walls. Act Obstet Gynecol Scand 1993; 72: 10-15.
2. Callam MJ. Epidemiology of varicose veins. Brit J Surg 1994; 81: 167-173.
3. Chiesa R, Marone EM, Limoni C et al. Demographic factors and their relationship with the presence of CVI signs in Italy: The 24-Cities Cohort Study. Eur J Vasc Endo Surg 2005; 30: 674-680
4. Dell DL. Premenstrual syndrome, premenstrual dysphoric disorder, and premenstrual exacerbation of another disorder. Clin Obstet Gynecol 2004; 47: 568-675.
5. Duckles SP, Krause DN, Miller VM. Effects of gonadal steroids on vascular function. J Pharmacol Exp Ther 1996; 279: 1-3.
6. Erikson H, Gustafson JA. Steroid Hormone Receptors: Strukture and Funktion. Nobel Symmposium 57. Amsterdam, Nederlands: Elsevier Sciences Publishing Co. 1988.
7. Evans CJ, Fowkes FG, Ruckley CV et al. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidem and Comm Health 1999; 53: 149-153.
8. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB 1996; 10.
9. Gearge J Jr, Rutheford RB. Varicose veins: patient selection and treatment. In: Ruthefort RB (ed). Vascular surgery. Philadelphia: WB. Saunders Company 1995: 1825-1828.
10. Goldman MP, Weiss RA, Bergan JJ. Diagnosis and treatment of varicose veins: a review. J Am Acad Dermatol 1994; 31: 394-413.
11. Knockx MM, Knaapen MWM, Bortier HE et al. Vascular remodeling in varicose veins. Angiology 1998; 11: 871-877.
12. Krasinski Z, Kotwicka M, Oszkinis et al. Badania nad patogeneza zylaków pierwotnych konczyn dolnych. Wiadomosci Lekarskie 1997; 50: 10-12.
13. Losordo L. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal woman. Circulation 1994; 89: 1501-1510.
14. Lyon KE, Lyon MA. The premenstrual syndrome. J Reprod Med 1984; 29: 705-711.
15. Mashiah A, Ben-Hur H, Thole HH. Estrogen and progesterone receptors in normal saphenous vein in male and female. Phlebology 1995 (Suppl 1): 214-216.
16. O'Brien PM. Helping women with premenstrual syndrome. Br Med J 1993; 307: 1471-1475.
17. O'Brien PMS. Premenstrual Syndrome. Oxford: Blackwell Scientific 1987.
18. Perrot-Applanat M. Progesterone receptor expression in human saphenous veins. Circulation 1995; 10: 2975-2983.
19. Ransom S, Moldenhauer J. Premenstrual syndrome. The Physician and Sportmedicine 1998; 26: 35.
20. Renaudin JM, Fiscel C, Mercier F et al. Smooth muscle differentiation in human vein wall at valvular level: Comparison with nonvalvular wall and correlation with venous function. Angiology 1999; 50: 21-30.
21. Rose SS, Ahmed A. Some thougs on the etiology of varicose veins. J Cardiovasc Surg 1986; 27: 534-543.
22. Ruckley CV. Treatment of venous ulceration. Compression therapy. Phlebology 1992; 7: 22-26.
23. Schmidt JB, Seidl K, Spona J. Hormonale Interaktionen bei Varikosis - Rezeptoranalyse und Hormonserumspiegel. VASA 1986; 3: 224-227.
24. Schultz-Ehrenburg U, Weindorf N, Matthes U et ai. New epidemiological findings with regard to initial stages of varicose veins (Bochum study I-III). Phlebologie 1992; 21: 234-236.
25. Suzuki A. Effects of 17 beta-estradiol and progesterone on growth-factor-induced proloferation and migration in human femal aoetic smooth muscle cells in vitro. Cardiovasc Res 1996; 32: 516-523.